Advertisement

Investigational New Drugs

, Volume 19, Issue 4, pp 293–301 | Cite as

Gene Expression Profiling of Exposure to TZT-1027, a Novel Microtubule-Interfering Agent, in Non-Small Cell Lung Cancer PC-14 Cells and Astrocytes

  • Tsugitaka Natsume
  • Takashi Nakamura
  • Yasuhiro Koh
  • Motohiro Kobayashi
  • Nagahiro Saijo
  • Kazuto Nishio
Article

Abstract

Clinical use of TZT-1027, amicrotubule-interfering agent that inhibitsthe polymerization of tubulin, is expectedbecause of its potent effects on solidtumors. TZT-1027 is thought to act directlyon cellular microtubules, and arrest cellmitosis, however, the molecular mechanismsof the microtubule damage by TZT-1027 havenot been fully identified. To investigatethe possible novel mechanisms of action ofTZT-1027, we used the cDNA macroarraytechnique to examine its effect on theexpression of hundreds of tightlytranscriptionally controlled genes. We usedtwo cell lines, one was human non-smallcell lung carcinoma PC-14 cells as a modelfor cancer cells, and the other was humanastrocytes as a model for normal neuronalcells, because the dose-limiting-factor ofmicrotubule-interfering agents is mainlyperipheral neurotoxicity. mRNAs preparedfrom the PC-14 and astrocyte cell linestreated with TZT-1027 were compared with588 genes spotted onto the filter, andwhich gene groups TZT-1027 modulatedbetween the two cell lines wasinvestigated. TZT-1027 exposure modulatedexpression of a variety of genes includingthe genes encoding cell-cycle and growthregulators, receptors, angiogenesis andinvasion regulators, rho family smallGTPases and their regulators and growthfactors and cytokines. However, the way ofgene regulation by TZT-1027 exposure wasdifferent between PC-14 cells andastrocytes. Genes up-regulated in bothPC-14 cells and astrocytes were those forRAR-ε, TNFR 1 and 2 and so on.Specifically altered genes in PC-14 cells,such as the genes coding for cytokeratin 8,XPG, fau and the genes regulated only inPC-14 cells may be involved in theantitumor activity of TZT-1027. On theother hand, growth factor receptorprecursors was upregulated specifically inastrocytes by TZT-1027 and this generegulation only in astrocytes may becandidates related with neurotoxicity.

TZT-1027 an antimitotic agent CDNA array astrocytes lung cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Miyazaki K, Kobayashi M, Natsume T, Gondo M, Mikami T, Sakakibara K, Tsukagoshi S: Synthesis and antitumor activity of novel dolastatin 10 analogs. Chem Pharm Bull 43: 1706–1718, 1995Google Scholar
  2. 2.
    Kobayashi M, Natsume T, Tamaoki S, Watanabe J, Asano H, Mikami T, Miyasaka K, Miyazaki K, Gondo M, Sakakibara K, Tsukagoshi S: Antitumor activity of TZT-1027, a novel dolastatin 10 derivative. Jpn J Cancer Res 88: 316–327, 1997Google Scholar
  3. 3.
    Natsume T, Watanabe J, Tamaoki S, Fujio N, Miyasaka K, Koyayashi M: Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin. Jpn J Cancer Res 91: 737–747, 2000Google Scholar
  4. 4.
    Watanabe J, Natsume T, Fujio N, Miyasaka K, Koyayashi M: Induction of apoptosis in human cancer cells by TZT-1027, an antimicrotubule agent. Apoptosis 5: 345–353, 2000Google Scholar
  5. 5.
    Halder S, Basu A, Croce CM: Bcl-2 is the guardian of microtubule integrity. Cancer Res 57: 229–233, 1997Google Scholar
  6. 6.
    Blagosklonny MV, Giannakakou P, El-Diery WS, Kingston DGI, Higgs PI, Neckers L, Fojo T: Raf-1/Bcl-2 phosphorylation: A step from microtubule damage to cell death. Cancer Res 57: 130–135, 1997Google Scholar
  7. 7.
    Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63, 1983Google Scholar
  8. 8.
    DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Tent JM: Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nature Genetics 14: 457–460, 1996Google Scholar
  9. 9.
    DeRisi J, Iyer VR: Genomics and array technology. Curr Opin Oncol 11: 76–79, 1999Google Scholar
  10. 10.
    Carulli JP, Artinger M, Swain PM, Root CD, Chee L, Tulig C, Guerin J, Osborne M, Stein G, Lian J, Lomedico PT: High throughput analysis of differential gene expression. J Cell Biochem Suppl 31: 286–296, 1998Google Scholar
  11. 11.
    Bershadsky A, Chausovsky A, Becker E, Lyubimova A, Geiger B: Involvement of microtubules in the control of adhesiondependent signal transduction. Curr Biol 6: 1279–1289, 1996Google Scholar
  12. 12.
    Enomoto T: Microtubule disruption induces the formation of actin stress fibers and focal adhesions in cultured cells: possible involvement of the rho signal cascade. Cell Struct Funct 21: 317–326, 1996Google Scholar
  13. 13.
    Hayakawa K, Itoh T, Mutoh T, Sobue G: NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants. Brain Res 794: 313–319, 1998Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Tsugitaka Natsume
    • 1
    • 2
  • Takashi Nakamura
    • 1
  • Yasuhiro Koh
    • 1
  • Motohiro Kobayashi
    • 2
  • Nagahiro Saijo
    • 1
  • Kazuto Nishio
    • 1
  1. 1.Pharmacology DivisionNational Cancer Center Research InstituteTokyo
  2. 2.Teikoku Hormone Mfg. Co., Ltd.KanagawaJapan

Personalised recommendations